I 116th CONGRESS 1st Session H. R. 2700 IN THE HOUSE OF REPRESENTATIVES May 14, 2019 Mr. Burgess (for himself, Mr. Walden , Mr. Upton , Mr. McKinley , Mr. Carter of Georgia , Mr. Bucshon , Mr. Bilirakis , Mr. Mullin , Mrs. Rodgers of Washington , Mr. Long , Mr. Flores , Mr. Hudson , Mr. Shimkus , Mr. Walberg , Mr. Kinzinger , Mr. Olson , Mr. Johnson of Ohio , Mr. Guthrie , Mr. Griffith , Mr. Duncan , Mrs. Brooks of Indiana , Mr. Gianforte , Mr. Latta , Mr. Scalise , Mr. Sensenbrenner , Mr. Collins of Georgia , Mr. Stivers , Mr. Hill of Arkansas , Mr. Mitchell , and Mr. Hurd of Texas ) introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on the Judiciary , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To incentivize low-cost drug options and generic competition, and to provide extensions for community health centers and the National Health Service Corps, and for other purposes.